AlphaGrep UK Ltd’s New York Times NYT Stock Holding History

AlphaGrep UK Ltd’s Portfolio NYT Stock Details NYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,157	Closed	-$289K	–	892
2025 Q4	$289K	Buy	+4,157	New	+$258K	0.1%	451

Other funds holding NYT

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK Ltd's NYT Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of New York Times (NYT) in Q1 2026, closing a stake of 4,157 shares — an estimated $289K sold.

AlphaGrep UK Ltd first reported a position in NYT in Q4 2025 and held it in 1 quarter. The position peaked at $289K in Q4 2025. 629 funds tracked by Wall St. Rank hold NYT as of Q1 2026.

AlphaGrep UK Ltd reported no remaining New York Times position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 4,157 New York Times shares in Q1 2026, an estimated $289K.
AlphaGrep UK Ltd first reported a position in New York Times in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's New York Times position peaked at $289K in Q4 2025.
629 funds tracked by Wall St. Rank held New York Times as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.